O
53.31
2.88 (5.71%)
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Oruka Therapeutics, Inc. | Menurun | Menaik |
AISkor Stockmoo
-0.3
| Konsensus Penganalisis | -3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.25 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 3.82% |
| % Dimiliki oleh Institusi | 86.62% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Fairmount Funds Management Llc | 31 Dec 2025 | 3,705,262 |
| Remedium Capital Partners, Llc | 31 Dec 2025 | 1,552,414 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 73.00 (BTIG, 36.94%) | Beli |
| Median | 50.00 (-6.21%) | |
| Rendah | 45.00 (Wedbush, -15.59%) | Beli |
| Purata | 56.00 (5.05%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 29.95 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wedbush | 13 Jan 2026 | 45.00 (-15.59%) | Beli | 31.34 |
| BTIG | 12 Jan 2026 | 73.00 (36.93%) | Beli | 30.69 |
| UBS | 07 Jan 2026 | 50.00 (-6.21%) | Beli | 27.81 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001 |
| 06 Jan 2026 | Pengumuman | Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |